Lazard, Inc. ($LAZ) reported second-quarter 2026 revenue of $807.7 million, down 1.2% from a year earlier. Gross profit fell to $245.3 million, while operating profit came in at $37.6 million, reflecting a much sharper decline in profitability.
Bottom-line results weakened significantly, with net income attributable to common shareholders dropping to $4.8 million. Diluted earnings per share declined to $0.03, as higher costs and softer operating performance weighed on results.
Cash generation remained a key positive, with operating cash flow of $203.4 million. The company ended the quarter with $1.1 billion in cash and cash equivalents, while total liabilities stood at $3.3 billion.
- Revenue: $807.7 million
- Operating profit: $37.6 million
- Net income: $4.8 million
- Operating cash flow: $203.4 million
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Lazard, Inc. Insider Trading Activity
Lazard, Inc. insiders have traded $LAZ stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $LAZ stock by insiders over the last 6 months:
- PETER RICHARD ORSZAG (CEO & Chairman) has made 0 purchases and 2 sales selling 69,170 shares for an estimated $2,819,273.
- CHRISTOPHER HOGBIN (CEO Asset Management) has made 0 purchases and 2 sales selling 11,829 shares for an estimated $473,592.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Lazard, Inc. Hedge Fund Activity
We have seen 159 institutional investors add shares of Lazard, Inc. stock to their portfolio, and 146 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- QUBE RESEARCH & TECHNOLOGIES LTD added 863,727 shares (+980.0%) to their portfolio in Q1 2026, for an estimated $36,691,122
- PRICE T ROWE ASSOCIATES INC /MD/ added 794,579 shares (+9.0%) to their portfolio in Q1 2026, for an estimated $33,753,715
- FMR LLC removed 647,550 shares (-5.8%) from their portfolio in Q1 2026, for an estimated $27,507,923
- TWO SIGMA INVESTMENTS, LP added 598,623 shares (+170.6%) to their portfolio in Q1 2026, for an estimated $25,429,505
- ARIEL INVESTMENTS, LLC added 529,467 shares (+10.0%) to their portfolio in Q1 2026, for an estimated $22,491,758
- FISHER ASSET MANAGEMENT, LLC added 410,208 shares (+23.3%) to their portfolio in Q1 2026, for an estimated $17,425,635
- AE WEALTH MANAGEMENT LLC removed 351,332 shares (-97.0%) from their portfolio in Q1 2026, for an estimated $14,924,583
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Lazard, Inc. Analyst Ratings
Wall Street analysts have issued reports on $LAZ in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 01/30/2026
To track analyst ratings and price targets for Lazard, Inc., check out Quiver Quantitative's $LAZ forecast page.
Lazard, Inc. Price Targets
Multiple analysts have issued price targets for $LAZ recently. We have seen 6 analysts offer price targets for $LAZ in the last 6 months, with a median target of $48.0.
Here are some recent targets:
- Ryan Kenny from Morgan Stanley set a target price of $47.0 on 07/09/2026
- Stephen Biggar from Argus Research set a target price of $52.0 on 05/05/2026
- Alex Bond from Keefe, Bruyette & Woods set a target price of $49.0 on 05/04/2026
- Michael Brown from UBS set a target price of $44.0 on 05/04/2026
- Richard Ramsden from Goldman Sachs set a target price of $45.0 on 04/14/2026
- Devin Ryan from Citizens set a target price of $60.0 on 04/10/2026
